Porges Says Genzyme Management Seeking `Graceful Exit': Video
July 23 (Bloomberg) -- Geoffrey Porges, an analyst at Sanford C. Bernstein & Co., talks about a potential acquisition of Genzyme Corp. by Sanofi-Aventis SA. Sanofi, France’s biggest drugmaker, made a takeover approach to Genzyme, the largest maker of medicines for genetic diseases, about two weeks ago, said two people with knowledge of the matter. Porges talks with Matt Miller on Bloomberg Television's "Street Smart." Bloomberg's Dominic Chu also speaks. (Source: Bloomberg)
Geoffrey Porges, an analyst at Sanford C. Bernstein & Co., talks about a potential acquisition of Genzyme Corp. by Sanofi-Aventis SA.
Sanofi, France’s biggest drugmaker, made a takeover approach to Genzyme, the largest maker of medicines for genetic diseases, about two weeks ago, said two people with knowledge of the matter. Porges talks with Matt Miller on Bloomberg Television's "Street Smart." Bloomberg's Dominic Chu also speaks. (Source: Bloomberg)
Running time 03:59
Rate this Page